SCHEMBL5217558

SCHEMBL5217558

Cc1oc(-c2ccc(Br)cc2)nc1C(C)CO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 6/20 0.49
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
RAB9A P51151 6/20 0.39
NPC1 O15118 6/20 0.39
MAPT P10636 3/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 4/20 0.37
TSHR P16473 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
RXFP1 Q9HBX9 1/20 0.35
DGAT1 O75907 1/20 0.35
TP53 P04637 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500914 0.85 TARBP2 (0.49) TARBP2PPARGPPARARAB9ANPC1
SCHEMBL3579118 0.84 TARBP2 (0.50) TARBP2PPARGPPARARAB9ANPC1
SCHEMBL4467290 0.82 PTPN1 (0.47) PPARGPPARALMNA
SCHEMBL4484956 0.82 PTPN1 (0.47) PPARGPPARALMNA
SCHEMBL4482083 0.81 TARBP2 (0.39) TARBP2RAB9ANPC1MAPTKMT2A
SCHEMBL5215263 0.80 RAB9A (0.43) TARBP2PPARGPPARARAB9ANPC1
SCHEMBL5093853 0.75 TARBP2 (0.54) TARBP2PPARGPPARARAB9ANPC1
SCHEMBL5216035 0.75 TARBP2 (0.54) TARBP2PPARGPPARARAB9ANPC1
SCHEMBL4473360 0.75 TARBP2 (0.41) TARBP2RAB9ANPC1MAPTKMT2A
SCHEMBL1981068 0.73 PPARG (0.54) TARBP2PPARGPPARARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480640-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-08-15 EP disclosed
EP-1480640-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-08-15 EP disclosed
US-7153878-B2 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-12-26 US disclosed
US-20050107449-A1 Peroxisome proliferator activated receptor modulators ELILILLY AND COMPANY 2005-05-19 US disclosed
EP-1480640-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-12-01 EP disclosed
WO-2003072100-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107449-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD TARBP2 3484/4885PPARG 1/4885PPARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.